The antimicrobial susceptibility testing of the MICRONAUT-S/-AM plates is based on the rehydration of antibacterial agents and/or antifungal agents by the addition of a standardized suspension of bacteria or yeasts. The plates can be read after an incubation of 24-48 hours at a temperature of 30°C or 35-37°C (depending on test system and organism) with a reader or visually. Data recorded by automated reading can be evaluated and interpreted by MICRONAUT software.
Principle, shelf-life and storage
The susceptibility testing is based on the rehydration of antibiotics by adding a standardized bacteria suspension (Mueller-Hinton II broth). The result is measured photometrically after 18-24 hours incubation at 35-37°C. Results are going to be measured and interpreted either with the MICRONAUT software or visually. Due to a special vacuum drying method the plates can be stored at a room temperature of 15-25°C. The MICRONAUT test plates have a shelf life of 24 months at date of production.
The antibiotics configuration of the MICRONAUT-S MRSA GP plate allows the specific detection of the clinically relevant single or multi-resistances of gram-positive bacteria of nosocomial infection. The susceptibility testing with highly effictive reserve antibiotics like the MRSA cephalosprine Ceftaroline offers alternatives in case of extreme multi-resistance.
All information can be found in the product description MICRONAUT-S MRSA GP. The detailed layout is available on request.
Based on the micro-dilution procedure MICRONAUT‑S provides the phenotypical detection of clinically relevant cephalosporinases and carbapenemases at entero-bacteria and non-fermenters.
In recent years there was an increase worldwide in carbapenem resistance based on type D carbapenemase producing Enterobacteriaceae (type OXA-48). These secondary, plasmid encoded type D carbapenemases can be spread horizontally by plasmid transfer and therefore showing a potential of dissemination of high epidemiologic importance. Moreover the ß-lactamases resistance determinants are localized on mobile genetic elements (integrons) which are normally associated with additional resistance genes (e. g., aminoglycosides, fluoroquinolones etc.) bearing the high risk for the spread of multi-resistance among clinical relevant pathogens.
The novel standard plate MICRONAUT-S ß-Lactamases now includes temocillin and ertapenem-/meropenem screening concentrations for detection of low-level carbapenem resistance. These modifications improve the sensitivity of the test system for detection of OXA-48-like type D carbapenemases.
In the new MICRONAUT-S ß-Lactamases plate the drug concentrations of cefepime, cefotaxime, and ceftazidime are increased up to 128 µg/ml. Based on the new drug concentration ranges the sensitivity of the ESBL- and AMP-C confirmatory assay is raised by the reduction of “out of range” results.
All information can be found in the product description MICRONAUT-S ß-Lactamases. The detailed layout is available on request.
The new two-test-plate MICRONAUT-S Carbapenemases Detection, which is based on broth microdilution procedure, provides phenotypic detection of clinically relevant carbapenemases (type A carbapenemases (e.g. KPC), metallo-β-lactamases, and OXA-48-like type D carbapenemases) in enterobacteria and Pseudomonas aeruginosa.
In recent years, there was a steady increase of carbapenem resistance worldwide due to the spread of type D carbapenemase producing Enterobacteriaceae (type OXA-48-like). These secondary, plasmid encoded type D carbapenemases can be spread horizontally by plasmid transfer and are therefore of high epidemiologic importance. Moreover, the ß-lactamases resistance determinants are localized on mobile genetic elements (integrons), which may be associated with genes conferring resistance to other antibiotic classes (aminoglycosides, fluoroquinolones etc.). The latter is of high risk for the spread of multi-resistance among clinical relevant pathogens.
The new two-test plate MICRONAUT-S Carbapenemases Detection contains first the inhibitor combination meropenem / avibactam. The new beta-lactamase inhibitor avibactam shows inhibitory activity against type D carbapenemases. If temocillin high-level resistance is detected as well, an OXA-48-like type D carbapenemase can be phenotypically confirmed.
By selection of the concentration ranges of meropenem as mono compound (0.06 - 128 μg/ml) and the inhibitor combinations meropenem/3-amino-phenyl-borate (3- APB), meropenem/EDTA and meropenem/avibactam (each 0.031 - 32 μg/ml), the detection of type A carbapenemases (e.g. KPC), metallo-β-lactamases and OXA-48-like type D carbapenemases is possible when the meropenem screening cut-off concentration for enterobacteria is exceeded[1].
[1] EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance. EUCAST Version 2.0, July 2017
All information can be found in the product description MICRONAUT-S Carbapenemases Detection. The detailed layout is available on request.
Based on the micro-dilution procedure MICRONAUT-S MDR MRGN Screening provides the phenotypical detection of clinically relevant cephalosporinases and carbapenemases at entero-bacteria and non-fermenters.
NEW ⇒ Extended spectrum of antibiotics by meropenem screening concentrations for an improved detection of OXA-48-like type D carbapenemases
NEW ⇒ Extended spectrum of antibiotics by introduction of the novel antibiotic combinations ceftazidime-avibactam and ceftolozane-tazobactam
All information can be found in the product description MICRONAUT-S MDR MRGN-Screening. The detailed layout is available on request.
For MIC determination towards antimicrobial agents with high avctivity against anaerobes inclusive compounds like tigecycline, moxifloxacin, or ertapenem.
Further information provides the product description about MICRONAUT-S Anaerobes MIC
The susceptibility testing is based on the rehydration of antimycotics by adding a standardized yeast suspension. After incubation of 24-48 hours at 35-37ºC the plates are ready to be measured photometrically or be interpreted visually. Because of a special vacuum drying process the plates can be stored at a room temperature of 15-25°C. MICRONAUT test plates have a shelf life of 24 months at date of production.
Further details provides the product description about MICRONAUT-AM
Further MICRONAUT plates on demand. Don't hesitate to contact us. We develop the layout for your requirements.
Get here your deeper insight
Product descriptions